Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January-March 2021

ON THE WAY TO A STRONGER SERNEKEJanuary-March 2021 · Order bookings amounted to SEK 1,179 million (2,975) and the order backlog was SEK 13,126 million (10,576) · Revenue amounted to SEK 1,950 million (1,814) · Operating profit amounted to SEK 31 million (loss: 149) · Cash flow from operating activities amounted to an outflow of SEK 2 million (233) · Profit for the period amounted to SEK 46 million (loss: 106) · At the end of the period, available cash and cash equivalents amounted to SEK 704 million (646) · The equity/assets ratio was 36.2 percent (37.0) · On

Lipidor publishes interim report for Q1 2021

STOCKHOLM, Sweden, 6 May 2021: Today, Lipidor AB (publ) (Nasdaq First North: LIPI) publishes its interim report for the period January – March 2021. The quarterly report is available on the company's website (click here ) and in the attached pdf (in Swedish).Summary of the interim report – first quarter 2021 The period began with a signed license agreement with Cannassure Therapuetics Ltd, regarding medical cannabis products based on Lipidor's AKVANO® technology. Activities prior to the start of the Phase III study with AKP02, and

Optomed Plc: Interim Report, January – March 2021

Optomed Plc           Stock Exchange Release         6 May 2021 at 9:00, Helsinki Optomed Plc: Interim Report, January – March 2021 January – March 2021 · Revenue increased by 30.0 percent to EUR 3,944 (3,034) thousand. At comparable exchange rates, revenue grew by 30.4% · Devices segment revenue increased by 48.6 % to EUR 1,447 (974) thousand. At comparable exchange rates, the segment revenue grew by 49.9% · Software segment revenue increased by 21.2 % to EUR 2,497 (2,060) thousand · EBITDA amounted to EUR –315 (-575) thousand corresponding to –8.0 (-19.0) percent of

Citycon Q1/2021: Quarter over quarter growth

CITYCON OYJ   Interim Report   6 May 2021 at 09:00 hrs- NRI EUR 50.4 million -3.8% compared to Q1/2020: an improvement over the previous quarter- Total tenant sales at -4.7% y-o-y- Administrative expenses improved -13% y-o-y due to tight cost control- Direct operating profit EUR 44.9 million (-2.9%) reflecting NRI development- Slightly positive valuations supported by positive leasing momentum- Divestment of 3 non-core assets as a part of planned capital recycling and portfolio transformation- LTV lowered to 46.5% as a result of the divestment- Successful issue of EUR 350

Outokumpu interim report January–March 2021: Strong start to the year – adjusted EBITDA increased to EUR 177 million

Outokumpu OyjInterim reportMay 6, 2021 at 9.00 am EESTOutokumpu interim report January–March 2021: Strong start to the year – adjusted EBITDA increased to EUR 177 million  Highlights in January–March 2021 · Stainless steel deliveries were 608,000 tonnes (Q1/2020: 588,000 tonnes)[1]. · Adjusted EBITDA was EUR 177 million (EUR 106 million). · EBITDA was EUR 177 million (EUR 106 million). · Operating cash flow was EUR 27 million (EUR -32 million). · Net debt was EUR 1,073 million (December 31, 2020: EUR 1,028 million). · Gearing was 43.7% (December 31, 2020: 43.6%).

Karo Pharma to sell its treasury shares

Karo Pharma (“Karo”) pursues a growth strategy, which combines geographical expansion with an active acquisition strategy. To execute on this strategy, Karo needs capital and a strong financial position. The treasury shares represent an unutilized resource in the company and a sale of the shares enhances Karo’s financial flexibility. On October 30, 2020 Karo communicated its intentions to sell its treasury shares for the above purpose. This process has now been completed and Karo today announces the sale of all remaining (1,375,417) treasury shares, representing approximately 0.6% of the

CONTINUED IMPLEMENTATION OF MUNTERS STRATEGY – TAKING THE NEXT STEPS IN BUSINESS AREA FOODTECH

Munters is on a journey delivering on the strategy set forth early 2020. As part of this, business area FoodTech has completed a strategic review outlining measures to strengthen its digital offering and climate solutions part of the business. Implementation will start in the second quarter 2021.At the start of 2020 Munters launched a new strategy. Following this, a strategic review of the two business areas has been made. As a consequence, measures to sharpen the customer offering and optimize the footprint, mainly related to the business area AirTech, were announced in July 2020.

IRLAB interim report January - March 2021

Significant events during the first quarter (1 January – 31 March, 2021) · In January, new preclinical data were presented that indicates that not only can mesdopetam treat, but also prevent, the development of levodopa-induced dyskinesias (LIDs) in Parkinson’s. The new results increase the commercial potential of mesdopetam. · In January, results were also presented from a collaboration with Chalmers University of Technology, AI-company Smartr and IRLAB about the application of deep learning on multidimensional effects of CNS drugs. A summary of the interesting results were presented

Initiation of share repurchase program

The Board of Directors of Atea ASA has resolved to initiate a share repurchase program. The share repurchase program is in accordance with the power of attorney granted to the Board by the Annual General Meeting of Atea ASA on April 29, 2021. The share repurchase program will be for a maximum consideration of NOK 160 million, and for a maximum of 860,000 shares. The program will commence on May 6 and continue until June 30, 2021. Buyback transactions will be executed according to the market price on the Oslo Stock Exchange, and the maximum price to be paid per share under the program is

HKScan’s tenth consecutive profit improvement

HKScan Corporation, January-March Interim Report, 6 May 2021 at 8.30 a.m. Finnish timeHKScan’s Interim Report 1 January – 31 March 2021  HKScan’s tenth consecutive profit improvement  January–March 2021 · Comparable EBIT has improved for ten consecutive quarters year on year. · HKScan’s net sales totalled EUR 427.5 (428.9) million.  · Clear sales growth of the branded products continued in the retail channel. Food service sales decreased significantly due to the Covid-19 pandemic, but the fall started to level off at the end of the period.  · EBIT improved by EUR 2.8

Change in the Fiskars Group Leadership Team

Fiskars CorporationStock Exchange ReleaseMay 6, 2021 at 08:30 EEST  Change in the Fiskars Group Leadership Team Fiskars Group has appointed Jussi Siitonen as Chief Financial Officer and deputy to the CEO. He joins Fiskars Group from the leading premium sporting goods company Amer Sports, where he has been working since 2011 as Chief Financial Officer. Jussi will join Fiskars Group on November 3, 2021, at the latest. Sari Pohjonen, currently Chief Financial Officer and deputy to the CEO, has decided to leave the company. To support the transition, Sari will continue in her role

Strong start to the year with continued solid growth

Readly AB presents a strong quarter with continued solid growth. The number of full-paying subscribers increased by 36.8 per cent to 397,071 (290,156) at the end of the quarter. Revenues increased with 32.0 per cent to SEK 101.9 million (77.2). Gross profit increased by 34.4 per cent to SEK 33.9 million (25.2), corresponding to a gross margin of 33.2 per cent (32.7). - We started the year with a strong quarter with continued solid growth and we continue to deliver according to our strategy and in line with financial targets. All markets contributed with double-digit subscriber growth

Teleste 1-3/2021: Net sales on par with the reference period, adjusted operating result increased.

TELESTE CORPORATION       INTERIM REPORT  6 MAY 2021 AT 8:30 EET            TELESTE CORPORATION INTERIM REPORT 1 JANUARY TO 31 MARCH 2021 NET SALES ON PAR WITH THE REFERENCE PERIOD, ADJUSTED OPERATING RESULT INCREASED First quarter of 2021 - Net sales amounted to EUR 37.0 (36.6) million, an increase of 1.2%- Adjusted operating result stood at EUR 1.5 (1.4) million, an increase of 5.1%- Operating result amounted to EUR 4.7 (1.4) million, including non-recurring income from insurance compensation of EUR 3.2 million, an increase of 230.0%- Earnings per share were EUR 0.21 (-0.

Strong result with higher income, lower losses and good cost control

SpareBank 1 SR-Bank ASA (SRBNK) achieved a pre-tax profit of NOK 880 million for the first quarter of 2021, compared with NOK 247 million for the same quarter last year. The result was characterised by increased income, efficient operations and significantly lower impairment losses compared with the same period last year.  The return on equity after tax was 11.6%, compared with 3.4% for the same quarter last year. This is also an improvement on the previous quarter when the return on equity after tax was 9.7%. Impairment losses on loans and guarantees amounted to NOK 121 million,

Interim report, January - March 2021

Net sales increased by 19% Y-O-Y adjusted for exchange rate fluctuations. Consolidated net sales ended at 48,522 (SEK 000s). EBITDA totaled 837 (SEK 000s), 2% margin. Operating profit, EBIT, was -2,454 (SEK 000s). Profit after tax was 1,229 (SEK 000s). Earnings per share was SEK 0.02.CEO’S COMMENTS In the first quarter of 2021 the 24SevenOffice team continued doing a tremendous effort during the fourth quarter of the Covid-19 pandemic. Thanks to the technology-oriented culture and experience of remote working over a number of years the 24SevenOffice team achieved a lot from their home

Viking Line Abp: Invitation to the Annual General Meeting

Viking Line Abp             NOTICE TO GENERAL MEETING          06.05.2021, 8.10 AM  INVITATION TO THE ANNUAL GENERAL MEETING The shareholders in Viking Line Abp are invited to the Annual General Meeting, which will be held at 12.00 noon on Thursday, May 27, 2021, at Alandica Culture and Congress, Strandgatan 33, Mariehamn.The reception of persons who have registered for the meeting and the distribution of voting tickets will begin at 11.00 a.m. A. The items on the agenda of the Annual General Meeting The Annual General Meeting will deal with the following items of business:

Pioneering study explores passengers’ experiences of self-driving cars in winter conditions

Trust, safety and security are the most important factors affecting passengers’ attitudes towards self-driving cars. Younger people felt their personal security to be significantly better than older people. The findings are from a Finnish study into passengers’ attitudes towards, and experiences of, self-driving cars. The study is also the first in the world to examine passengers’ experiences of self-driving cars in winter conditions. The findings were published in Transportation Research Part F: Traffic Psychology and Behaviour. The study was carried out in collaboration between the

YIT has won numerous road maintenance contracts for 2021-2026

YIT has won four state road maintenance contracts for 2021-2026. The contracts cover Veteli, Lappeenranta, Raahe-Ylivieska and Karstula areas. The total value of the contracts is approximately EUR 57 million, and they will be booked in the order book of the second quarter of the year. The contracts will commence on October 1, 2020 and will last for five years. YIT manages public and private road and street networks in ELY centers, cities and municipalities. A collaborative project model is used for road maintenance contracts. YIT also carries out street and road construction as well as

Lehto Group Plc: Business Review January-March 2021

Lehto Group PlcBusiness Review January-March 20216 May 2021 at 8.00 a.m. (EET)Net sales down, operating result improves year-on-year, financial position remains good This is not an interim report as specified in the IAS 34 standard. The company complies with half-yearly reporting according to the Finnish Securities Markets Act and discloses regular business reviews for the first three and nine month periods of the year, in which key information regarding the company's financial situation and development will be presented. Summary January–March 2021 []Group

“Change runs on renewables” is not just a brand promise: Neste’s transformation is done with renewables, and it is profitable

Neste Corporation, News, 6 May, 2021 A decade after refocusing its strategy on renewable fuels and plastics, Neste’s Q1 2021 results show that the company is on track in creating the change needed to build a more sustainable future. Over the last decade, Neste has become a major player in renewables. Its transformation from a regional oil refinery to becoming a global leader in renewable and circular solutions speaks loudly about limitless curiosity, courage, hard work and perseverance. This inspiring journey has for example put Neste on the list of the 20 most

Odfjell SE: First quarter 2021 results impacted by seasonality and weather disruptions

Odfjell SE today reported its results for the first quarter of 2021. The report shows that the chemical tanker market and Odfjell’s results were negatively influenced by seasonality, disruptions of COA volumes caused by the unprecedented freeze in Texas, and a challenging CPP market.   Highlights for 1Q21 · Timecharter earnings in Odfjell Tankers of USD 120 million compared to USD 125 million in  4Q20 · Net result contribution from Odfjell Terminals of USD 0.2 million compared to USD -0.6 million 4Q20 · EBIT of USD 8 million compared to USD 18 million in 4Q20 · Net result

Targovax ASA: First quarter 2021 results

Oslo, Norway, 6 May 2021 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its first quarter 2021 results. An online presentation by Targovax’s management to investors, analysts and the press will take place at 10:00 CET today (details below).FIRST QUARTER HIGHLIGHTS REASEARCH & DEVELOPMENT · Reported continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up · Median Overall Survival (mOS) has still not been met for randomized first-

Veidekke ASA: Q1 2021 results and capital markets update

Veidekke is reporting its Q1 2021 results today and holding its capital markets update, at which the group will present targets and plans for further profitability improvements in the period to 2025.“We have improved profitability and the robustness of the project portfolio considerably over the past two years. However, Veidekke has further potential, and we have high operational ambitions for the years ahead,” says Group CEO Jimmy Bengtsson. Following the sale of the property development operation in 2020, Veidekke is now a streamlined construction company, and among the leading

Sedana Medical AB (publ), First Quarter Report 2021

A quarter of launch preparations and continued increase in sales, lifted by the pandemicFinancial Summary This interim report has been prepared in accordance with IFRS with function-based income statement compared with cost-based income statement as previously. January-March 2021 · Net sales for the first quarter totalled MSEK 45 (34), equivalent to an increase of 33% on the same quarter in 2020. At fixed exchange rates, sales increased by 40%. · Gross profit was MSEK 29 (23), equivalent to a margin of 64% (67%). The lower margin is principally an effect of the continued high

There are no items matching the current filter
There are no more items matching the current filter
Back to top